Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial
- DOI
- 10.1016/j.jinf.2023.04.012
- Published
- 2023-07
- Container
- Journal of Infection
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jinf.2023.04.012,
title = {Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial},
author = {Xinxue Liu and Alasdair P S Munro and Annie Wright and Shuo Feng and Leila Janani and Parvinder K Aley and Gavin Babbage and Jonathan Baker and David Baxter and Tanveer Bawa and Marcin Bula and Katrina Cathie and Krishna Chatterjee and Kate Dodd and Yvanne Enever and Lauren Fox and Ehsaan Qureshi and Anna L. Goodman and Christopher A Green and John Haughney and Alexander Hicks and Christine E Jones and Nasir Kanji and Agatha A. van der Klaauw and Vincenzo Libri and Martin J Llewelyn and Rebecca Mansfield and Mina Maallah and Alastair C McGregor and Angela M. Minassian and Patrick Moore and Mehmood Mughal and Yama F Mujadidi and Hanane Trari Belhadef and Kyra Holliday and Orod Osanlou and Rostam Osanlou and Daniel R Owens and Mihaela Pacurar and Adrian Palfreeman and Daniel Pan and Tommy Rampling and Karen Regan and Stephen Saich and Dinesh Saralaya and Sunil Sharma and Ray Sheridan and Matthew Stokes and Emma C Thomson and Shirley Todd and Chris Twelves and Robert C. Read and Sue Charlton and Bassam Hallis and Mary Ramsay and Nick Andrews and Teresa Lambe and Jonathan S Nguyen-Van-Tam and Victoria Cornelius and Matthew D Snape and Saul N Faust},
year = {2023},
journal = {Journal of Infection},
doi = {10.1016/j.jinf.2023.04.012},
url = {https://doi.org/10.1016/j.jinf.2023.04.012}
}RIS
TY - JOUR TI - Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial AU - Xinxue Liu AU - Alasdair P S Munro AU - Annie Wright AU - Shuo Feng AU - Leila Janani AU - Parvinder K Aley AU - Gavin Babbage AU - Jonathan Baker AU - David Baxter AU - Tanveer Bawa AU - Marcin Bula AU - Katrina Cathie AU - Krishna Chatterjee AU - Kate Dodd AU - Yvanne Enever AU - Lauren Fox AU - Ehsaan Qureshi AU - Anna L. Goodman AU - Christopher A Green AU - John Haughney AU - Alexander Hicks AU - Christine E Jones AU - Nasir Kanji AU - Agatha A. van der Klaauw AU - Vincenzo Libri AU - Martin J Llewelyn AU - Rebecca Mansfield AU - Mina Maallah AU - Alastair C McGregor AU - Angela M. Minassian AU - Patrick Moore AU - Mehmood Mughal AU - Yama F Mujadidi AU - Hanane Trari Belhadef AU - Kyra Holliday AU - Orod Osanlou AU - Rostam Osanlou AU - Daniel R Owens AU - Mihaela Pacurar AU - Adrian Palfreeman AU - Daniel Pan AU - Tommy Rampling AU - Karen Regan AU - Stephen Saich AU - Dinesh Saralaya AU - Sunil Sharma AU - Ray Sheridan AU - Matthew Stokes AU - Emma C Thomson AU - Shirley Todd AU - Chris Twelves AU - Robert C. Read AU - Sue Charlton AU - Bassam Hallis AU - Mary Ramsay AU - Nick Andrews AU - Teresa Lambe AU - Jonathan S Nguyen-Van-Tam AU - Victoria Cornelius AU - Matthew D Snape AU - Saul N Faust PY - 2023 JO - Journal of Infection DO - 10.1016/j.jinf.2023.04.012 UR - https://doi.org/10.1016/j.jinf.2023.04.012 ER -
APA
Liu, X., Munro, A. P. S., Wright, A., Feng, S., Janani, L., Aley, P. K., Babbage, G., Baker, J., Baxter, D., Bawa, T., Bula, M., Cathie, K., Chatterjee, K., Dodd, K., Enever, Y., Fox, L., Qureshi, E., Goodman, A. L., Green, C. A., Haughney, J., Hicks, A., Jones, C. E., Kanji, N., Klaauw, A. A. V. D., Libri, V., Llewelyn, M. J., Mansfield, R., Maallah, M., McGregor, A. C., Minassian, A. M., Moore, P., Mughal, M., Mujadidi, Y. F., Belhadef, H. T., Holliday, K., Osanlou, O., Osanlou, R., Owens, D. R., Pacurar, M., Palfreeman, A., Pan, D., Rampling, T., Regan, K., Saich, S., Saralaya, D., Sharma, S., Sheridan, R., Stokes, M., Thomson, E. C., Todd, S., Twelves, C., Read, R. C., Charlton, S., Hallis, B., Ramsay, M., Andrews, N., Lambe, T., Nguyen-Van-Tam, J. S., Cornelius, V., Snape, M. D., & Faust, S. N. (2023). Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial. Journal of Infection. https://doi.org/10.1016/j.jinf.2023.04.012
Source records
- crossref · retrieved 2026-09-25T11:42:10.256Z